SLX-4090 is an orally active enterocytic-specific microsomal triglyceride transfer protein ( MTP ) inhibitor with an IC 50 of 8.0 nM. SLX-4090 can be used for the research of dyslipidemia.
Products | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Lipid Metabolism | Products > Disease Areas > Obesity | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > Microsomal Triglyceride Transfer Protein (MTP)
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.